In patients with acute pulmonary embolism (PE), right ventricular dysfunction (RVD) on admission, as assessed by echocardiography, is a predictor of adverse in-hospital and 3-month clinical outcomes.
1,2 After the acute phase of PE, RVD usually regresses,
3-7 although it may persist despite treatment.
8,9 Data about the prevalence of persistent RVD are conflicting
6,8,9 probably because of differences in patient selection, criteria used to identify RVD, and follow-up duration. Moreover, although one study
9 indicated that RVD persistence is a predictor of adverse long-term prognosis, it did not specifically assess the incidence of recurrent venous thromboembolism (VTE) in patients with RVD persistence compared with those without RVD or with RVD regression.